Page last updated: 2024-08-24

1,5-anhydroglucitol and Myocardial Infarction

1,5-anhydroglucitol has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akashi, N; Ako, J; Arao, K; Fujiwara, T; Funayama, H; Kakei, M; Katayama, T; Mitsuhashi, T; Momomura, S; Nakamura, T; Sakakura, K; Sugawara, Y; Tsukui, T; Umemoto, T; Wada, H; Yamada, H; Yoshida, M	1

Other Studies

1 other study(ies) available for 1,5-anhydroglucitol and Myocardial Infarction

Article	Year
Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention. Heart and vessels, 2016, Volume: 31, Issue:6 Topics: Aged; Biomarkers; Blood Glucose; Chi-Square Distribution; Coronary Angiography; Deoxyglucose; Diabetes Mellitus; Down-Regulation; Female; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome	2016

Article

Year

Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention.

Heart and vessels, 2016, Volume: 31, Issue:6

Topics: Aged; Biomarkers; Blood Glucose; Chi-Square Distribution; Coronary Angiography; Deoxyglucose; Diabetes Mellitus; Down-Regulation; Female; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome

2016